First-of-its-kind Canine Health Study Enrolls 3,000th

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
First-of-its-kind Canine Health Study Enrolls 3,000th Golden Retriever

DENVER, March 24, 2015 (GLOBE NEWSWIRE) -- Chloe may not realize it, but she is a very special Golden Retriever. As the 3,000 th dog enrolled in the landmark Morris Animal Foundation Golden Retriever Lifetime Study, Chloe will help scientists better understand the role of environment, nutrition, exercise, behavior, genetics and other factors in the development of (or protection from) canine diseases—particularly the greatest health threat to all dogs, cancer.

"Today, we enrolled our last group of Golden Retrievers. We are extraordinarily grateful not only to the thousands of owners who enrolled their dogs in this study, but also to the many veterinarians who are on the front lines helping us gather data," said David Haworth, DVM, PhD, President/CEO of Morris Animal Foundation, a nonprofit organization that invests in science to advance animal health worldwide. "Of course, the real heroes are all the beautiful Golden Retrievers we will be following throughout their lives."

While common in human medical research, longitudinal studies of this magnitude that record lifestyle details and collect biological samples from subjects over an extended period of time, have not been done before in veterinary medicine. Such long-term studies can reveal health effects that evolve over many years—such as the link between cigarette smoking and lung cancer in humans—helping to unravel mysteries surrounding causes of disease and revealing clues to good health. The Golden Retriever Lifetime Study, funded and managed by Morris Animal Foundation, is the first of its kind in the veterinary world.

"A study like this can only happen through the active participation of an extended community of dog owners, dogs, veterinarians and study sponsors," Dr. Haworth said. "I think I can say with absolute certainty that we have one of the most active groups of study subjects of any longitudinal health study ever initiated. They are, after all, Golden Retrievers!"

Though the study focuses on Golden Retrievers, Dr. Haworth said other dog breeds and even other species, including humans, will benefit from what is learned.

"When we look at the similarities among animal species, we can see that there will be health risk or benefit factors that we can extrapolate from this study to other dog breeds or even to other animals," Dr. Haworth said. "The study will provide its own revelations about risk factors and disease correlations, and possible causations, as well as lead us to new areas of scientific inquiry both in veterinary and human medicine."

Similar to ongoing longitudinal studies in humans; veterinarians, dog owners and dogs won't have to wait until the Golden Retriever Lifetime Study is complete to see results that may help influence and improve veterinary and human medicine. Data is streaming into the study real-time and trends, once validated, will be published as they emerge.

"Some tests are run immediately and the results are returned to study veterinarians. Other samples are stored for future analysis," said Rod Page, DVM, ACVIM (Oncology), Director of the Flint Animal Cancer Center at Colorado State University, and Principal Investigator for the Golden Retriever Lifetime Study. "The questionnaire data actually is analyzed on a running basis every six months. In other words, it isn't being put aside for evaluation at a later date. Our goal is to share the findings as quickly as possible once we feel comfortable that the statistics support a solid trend. We want to have positive impacts on animal health not only in the future, but also for our patients today."

Nearly 70 years ago, Dr. Mark L. Morris, Sr., founded Morris Animal Foundation to fund the very best in scientific research to further the health and well-being of all animals. The Golden Retriever Lifetime Study is the largest of the more than 2,300 studies funded by the Foundation to date.
 
"The Golden Retriever Lifetime Study builds on the founding principle of the Foundation to invest in science that improves animal health," Dr. Haworth said. "The study exemplifies the Foundation's ongoing quest for new discoveries and knowledge that will make a difference in the lives of animals today and tomorrow."
 
Today, Morris Animal Foundation is a global leader in:

  • Innovation: Dr. Morris created the first veterinary prescription diet to specifically address diseases in dogs.
     
  • Rapid response: When the feline leukemia virus was first identified 50 years ago, Morris Animal Foundation invested in research that led to the development of the feline leukemia vaccine.
     
  • Cutting-edge research: The Foundation has invested in sophisticated medical technology enabling the genetic research that led to development of a diagnostic test for lavender foal syndrome, a deadly genetic disease that afflicts young horses.
     
  • Impactful science: The Foundation's efforts in wildlife health have resulted in important legislative changes to improve the well-being of many wildlife species including Argentinian waterfowl and California sea otters.

The Golden Retriever Lifetime Study would not be possible without the generous support of the study's sponsors. The Founding Partner is The Morris Family Foundation. Platinum sponsors for the study are The Blue Buffalo Foundation for Cancer Research, Petco, Zoetis and VCA Antech, Inc. Additional sponsors include the Golden Retriever Foundation, the Hadley and Marion Stuart Foundation and Mars Veterinary.
 
Stay up to date on the latest findings from the Golden Retriever Lifetime Study by following the study blog at caninelifetimehealth.org . To read more about Chloe's story, click here . Subscribe to AnimalNews for study updates and all the latest news from Morris Animal Foundation at morrisanimalfoundation.org .
 
Morris Animal Foundation

Morris Animal Foundation is a nonprofit organization that invests in science to advance animal health. The Foundation is a global leader in funding scientific studies for companion animals, horses and wildlife. Since its founding in 1948, Morris Animal Foundation has invested more than $92 million toward 2,300 studies that have led to significant breakthroughs in diagnostics, treatments, preventions and cures for animals worldwide. Learn more at morrisanimalfoundation.org . 

Tina M. Martinez 303.708.3418

Scroll down for more posts ▼

Top 10 Most Recent News Articles

APEC's Shenzhen Signal Is Bigger Than a Two-Day Summit

Updated Category News Views 92

Shenzhen spent two days trying to turn regional anxiety into a workable agenda. The APEC CEO Summit 2026, held November 17 and 18 at the Qianhai International Convention Center, brought together more than 2,000 political and business leaders from all 21 APEC economies and 13 economies outside the group. That is a serious room, not a ceremonial photo line. Still, investors...

Continue Reading
Dallas College Recognition Signals Workforce Value

Updated Category News Views 63

Economic mobility rarely arrives with brass bands, but it can show up in a community-college ranking. Dallas College has landed on TIME and Statista's inaugural America’s Best Community Colleges 2027 list, one of 250 schools selected from roughly 1,100 nationwide. For a region that keeps talking about talent pipelines, this is a useful piece of outside validation—not...

Continue Reading
S&P Global's UBS AI Conference Slot Deserves Attention

Updated Category News Views 109

Thirty Minutes Can Still Matter A half-hour fireside chat is not a quarterly earnings call, and anybody treating it like one is setting themselves up for disappointment. Still, S&P Global CEO Martina Cheung appearing at the UBS Global Technology and AI Conference on December 2 deserves a spot on the calendar for owners of NYSE:SPGI. This is a company sitting in the middle...

Continue Reading
TEN Holdings Raises $1.0 Million as Dilution Looms

Updated Category News Views 66

A Small Raise With a Loud Message Nothing says “we need room to breathe” quite like selling 1,492,500 new shares for $0.67 apiece. TEN Holdings closed a roughly $1.0 million gross equity offering on November 20, 2026, and investors in NASDAQ:XHLD ought to look at this for what it is: a modest cash infusion that comes with immediate dilution. The company gets capital;...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 81

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
California Initiative Puts Missed Diagnoses in Focus

Updated Category News Views 73

When Reassurance Turns Into a Risk A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 93

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
Delayed Remodels Can Quietly Drain Your Home's Value

Updated Category News Views 91

A pinhole leak has a nasty talent for becoming a demolition budget. That is the plain lesson in Jason Marks' discussion of delayed remodeling for homeowners in Kernersville, North Carolina. People tend to see a worn bathroom, tired kitchen, or drafty window and think, “Not pretty, but it can wait.” Sometimes it can. Sometimes that little delay lets water, rot,...

Continue Reading
Debevoise Builds Its PE M&A Bench With McBain Hire

Updated Category News Views 92

Law-firm hiring rarely makes a market blink, yet this one carries a decent whiff of where the deal work is gathering. Debevoise & Plimpton has brought Jenna McBain into its New York Mergers & Acquisitions Group as a partner, putting another experienced private-equity adviser on a platform the firm plainly intends to keep enlarging. McBain arrives from Weil, Gotshal &...

Continue Reading
Page Library Grant Makes a Practical Case for Access

Updated Category News Views 56

A library card is not much use if a family cannot reach the help behind it. That plain reality sits at the center of AZ Blue Health Choice’s $10,000 contribution to the Page Public Library Family Resource Center, announced November 20, 2026. This is a modest dollar figure in the grand scheme of health care, but it is aimed at the kind of everyday gaps that can become...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Urged to Join Flywire Corporation Securities Class Action

Updated Category News Views 219

Investors Urged to Join Flywire Corporation Securities Class Action The recent developments surrounding Flywire Corporation (NASDAQ: FLYW) have captured the attention of investors, especially those who purchased securities during the specified period. The Rosen Law Firm, known for championing investor rights, is taking the lead in facilitating a securities fraud lawsuit...

Continue Reading
Unicycive Therapeutics Faces Investigation Over Stock Concerns

Updated Category News Views 231

Unicycive Therapeutics Under Investigation for Securities Fraud In recent developments, Pomerantz LLP has initiated an investigation into the possible fraudulent activities involving Unicycive Therapeutics, Inc. (NASDAQ: UNCY). The inquiry focuses on whether the company and its executives may have violated securities laws, an issue that could have implications for many...

Continue Reading
Investors Urged to Act: Join Wolfspeed's Upcoming Class Action

Updated Category News Views 313

Overview of Wolfspeed's Class Action Wolfspeed, Inc. investors are encouraged to take action regarding their stakes in the company as a class action lawsuit surfaces. The Rosen Law Firm, a reputable entity specializing in investor rights, sets a significant deadline for participation in this case. It’s essential for anyone who purchased shares within the specified...

Continue Reading
Pacsun Champions Co-Creation at Music's Grandest Stage

Updated Category News Views 194

Pacsun Champions Co-Creation at Music's Grandest Stage Youth Retailer Debuts Co-Branded Merchandise and Artist Performances As Grammy Weekend celebrates the top talents in music, Pacsun embraces the opportunity to highlight the emerging artists and professionals shaping the future of music. Their approach emphasizes co-creation, access, and cultural participation, crucial...

Continue Reading
Vistra Corp Enhances Financial Stability with Credit Facility Boost

Updated Category News Views 134

Vistra Corp Strengthens Financial Flexibility In a strategic move to enhance its financial flexibility, Vistra Corp. (NYSE:VST), known for delivering electric services, has taken steps to amend its credit agreement. The changes not only extend the maturity date of its credit facility but also expand its borrowing capabilities. This adjustment, effective October 2, 2024,...

Continue Reading